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(Opinion expressed 5 March 1982) EÍPQRI_OF_THE_SÇIENTIFIÇ_ÇOMMIIIEE_FOR_FOOD_ON_AÇRYLONnRILE_MO 
(Opinion expressed 15 January 1981) 
IÍEMS_QF_REFERENÇE 
To evaluate the hazards to human health arising from the migration into food of acrylonitrile 
monomer present in certain plastic materials and articles intended to come into contact with 
foodstuffs. 
DISCUSSION 
The Committee considered the available technological and toxicological information as well as 
the epidemiological data on acrylonitrile monomer (AN) presented to it during 1978 and 1979 
and suggested at that time that before making a final decision it should see the results 
of ongoing studies. In the intervening period the Committee recommended that on the basis of 
the then available evidence AN should not be detectable in food or beverages by an agreed 
method. The Committee's views were made known to the responsible authorities. Since that 
time other information has become available and the Committee has now reviewed all the data. 
The toxicological data show that AN administered to rats orally or by inhalation induces 
tumours in various specific organs in a dose-related manner primarily in the central nervous 
system, Zymbal gland, tongue and forestomach. This increase is induced by concentrations 
in the diet above 1 mg/kg. AN also induces foetal malformations and early resorptions in 
rats. AN is mutagenic when tested in some bacterial systems but not in others. The 
mutagenicity tests in eukaryotic systems with and without metabolic activation yield no 
conclusive results. 
# 
The epidemiological studies indicate an increase in total tumour frequency, but there is 
so far no clear evidence for an increased occurrence of specific tumours among exposed 
workers. An increased incidence of symptoms relating to the central nervous system, 
cardiovascular system and haematopoetic system has been reported in exposed workers. 
C0NCLUŞI0NŞ_AND_REC0M51ENDAŢI0NŞ 
The Committee considers AN to be carcinogen for animals and possibly for man. The aim should 
therefore be to take all possible steps to reduce all forms of exposure to AN. The Committee 
recommends that the levels of AN monomer residue in materials and articles, intended to come 
into contact with foodstuffs, should be reduced as much as possible. In every instance AN 
should not be detectable in food by a method of analysis which would be applicable generally 
to most foods by most control laboratories. 
The analytical methods available today have a limit of detection of 0.005-0.01 mg/kg. 
Attempts should be made to develop a method with greater sensitivity. 
The Committee also recommends that the situation be reviewed at intervals in the light of 
further data collected in member countries and as progress is made in manufacturing technology. RIE2RI_Q£_IbI_SÇIINIIFIÇ_ÇgMMIITEE_FgR_F00D_0N_yiNYLIDENE 
(Opinion expressed 15 January 1981) 
IÍSÍ3S_0F_REFERENÇE 
To evaluate the hazards to human health arising from the migration into food of vinylidene 
chloride monomer (VDC) present in certain plastics materials and articles intended to come 
into contact with foodstuffs. 
DISCUSSION 
The Committee first considered the technological and toxicological information on vinylidene 
chloride monomer (VDC) available to it in 1978/79. The Committee was informed at that time 
of the progress of ongoing investigations in a number of countries. The data examined 
showed that VDC was carcinogenic when tested in mice. There was no evidence of carcinogenicity 
when tested in rats and hamsters and such human epidemiological evidence as was available 
from occupational exposure provided no evidence of a carcinogenic risk for man. The 
Committee also received evidence that significant migration of VDC from packaging materials 
and articles into food did not occur. On this basis the Committee was prepared to accept 
provisionally the continued use of packaging material made from VDC on condition that more 
information was supplied on exposure to VDC via food which is in contact with packaging 
material and articles containing VDC. In addition, the results of ongoing studies on the 
toxicology and epidemiology of VDC were requested to be made available to the Committee. 
The Committee recommended that in the meantime every effort should be made to reduce the 
levels of VDC in packaging materials and articles to the minimum . These views were made 
known to the responsible authorities. 
The Committee has now considered the additional technological and toxicological information 
on VDC which has become available since its earlier review. This additional evidence includes 
information on the bio-chemistry, metabolism, pharmacokinetics, reproduction and teratology, 
carcinogenicity and mutagenicity of VDC following both oral administration and exposure by 
inhalation. 
The previously observed carcinogenic effect in mice is now considered to be specific for 
this species and related to the cytotoxic action on the mouse kidney as the primary target 
organ rather than to any direct interaction with cellular DNA. This view is based on the 
observation that VDC and its metabolites with an epoxide structure are eliminated essentially 
by reaction with glutathione or bind covalently with cellular macromolecules, though only a 
minimal extent with DNA. 
The toxicological data now available from other species have shown the absence of any 
significant toxic potential of VDC for the rat, the Chinese hamster and the rabbit with 
regard to reproduction and teratology as well as carcinogenicity and, include one long-term 
study. Thesr studies are, however, insufficient to establish a TDI . 
The technological data have revealed that with the exception of a few oily food wrapped in 
films coated with VDC/VC copolymer, the levels of VDC in food generally are very low and of 
the order of 0.001 mg/kg food. In the few oily foods wrapped in films coated with VDC/VC 
polymer which have been examined, the levels of VDC ranges from 0.02-0.31 mg/kg food. 
C0NCLyŞI0NŞ_AND_RECgMMENDAŢI0NŞ 
The Committee has no objection on toxicological grounds to accepting the continued use of plast 
materials and articles made with VDC and intended to come into contact with foodstuffs. 
Nevertheless because the Committee was unable to establish a TDI for this monomer, it recommend 
that the Levels of VDC monomer residues in materials and articles intended to come into 
contact with foodstuffs should be reduced as much as possible. 
Tolerable Daily Intake : See Reports of the Scientific Committee for Food, 6th Series (1978) REPORT OF THE SCIENTIFIC C0MMITTEE FOR FOOD ON HYDROLYSED LECITHIN 
(Opinion expressed 12 June 1981) 
TERMS OF REFERENCE 
To give an opinion on the acceptability from the point of view of public health of the use 
in food of hydrolysed lecithin as an alternative to non-hydrolysed lecithins. 
BACKGROUND 
When purity criteria for lecithins (E 322) were being drawn up, a number of questions were 
raised on whether it was possible to include "hydrolysed lecithins" within the term 
"lecithins". The Council decided that the Commission should make further enquiries before 
these materials could be approved for use at Community level. 
As part of its investigation, the Commission has asked the Committee to advise on the safety 
aspects. 
CURRENT REVIEW 
The Committee was informed that food grade lecithin, obtained from soya beans or other 
sources, is a mixture containing about 60% phospholipids and 40% of triglycerides, sterols 
and carbohydrates in various proportions. Hydrolysed lecithin has been proposed as a 
replacement of lecithin and is the product of partial hydrolysis of food grade lecithin 
following digestion with pancreatin. 
The available specification shows that hydrolysed lecithin contains about 51% phosphatides, 
18% total free fatty acids, 1% moisture and 24% of triglycerides, sterols, commercial 
pancreation and carbohydrates in variable proportions. 
Hydrolysed lecithin is biochemically closely related to lecithin from which it is derived 
by enzymatic hydrolysis. It therefore contains additional free acids and glycerophosphate 
fragments. The pathways of phosphatide synthesis and catabolism are well known. The 
average diet provides a daily intake of several grams (1-5 grams of lecithin). 
A three week feeding-study in rats comparing lecithin, hydrolysed lecithin and a control 
purified diet containing 10% ground nut oil showed no essential difference between lecithin 
and hydrolysed lecithin with respect to effects on body weight, food intake and growth. Level: 
of 20% or more in the diet produced adverse effects on haematopoiesis and enlargement of 
the kidneys^. 
Another rat study extending over 90 days with a similar design showed that the feeding of 
lecithin or hydrolysed lecithin at levels of 5% or less in the diet induced no adverse 
effects and no clear dose-related effect was seen at dietary levels up to 20%. The renal 
lesions observed were considered to be specific to the Colworth rat and are therefore not 
significant for human health'' . 
CONCLUSIONS, 
Hydrolysed lecithin is produced in the gut as a result of normal digestion. There appears to 
be no specific toxicologicei effect in rats due to feeding of hydrolysed lecithin·. This 
substance can therefore be regarded metabolically and toxicologically as an alternative to 
lecithin. 
REFERENCES 
1. UNILEVER, 1978, unpublished study "Biological Safety Evaluation of Hydrolysed Lecithin 
(B0LEC M) submitted to the EEC Commission. 
2. WHO, 1974, Food Additive Series, No. 5, p. 234. ŞI£QND_REPgRI_gF_ŢHE_ŞCIENŢIFIC_CgMMIIIEE_FQR_FOg 
(Opinion expressed 12 June 1981) 
IÍ5!3S_QF_REFERENÇE 
The Committee was asked to give an opinion on the safety of the chemically modified 
starches, permitted on a temporary basis until 31 December 1980 and listed in groups Β 
and C of the Appendix to its report. t 
BACKGROUND 
it 
In its first report on modified starches of 1976 the Scientific Committee for Food requested 
further studies on the appearance and mechanism underlying the observed pelvic nephrocalcinosis 
as well as certain studies on individual modified starches. The results of these studies 
were to be reviewed before the 31 December 1980. 
On the other hand the Committee noted that among starches, previously classified in its 
earlier report in group C, those modified by epichlorhydrin were no longer used by industry, 
although the results of toxicological studies have become available for some of these 
modified starches. The Committee noted that the specifications in the Annex to its Report 
of 1976 had been reexamined by the Commission and that a number of modifications had been 
made that were not essential to the toxicological evaluation. 
IQXIÇgLgGIÇAL_EVALUATigN 
a) §îydieş_of_neghroçalcinoşiş_(PN) 
The Committee has now been supplied with a number of documents (1, 2, 3, 4, 5, 6, 7, 8) 
relating to this problem. The review by Dr. F.J.C. Roe appraised the relevant literature 
on mineral deposition in the renal pelvis of rats. Probably the most important factors 
contributing to renal manifestations of dietary mineral and vitamin imbalance in rats 
were the. dietary levels of Ca, Mg, Ρ and vitamin Β.. Three kinds of nephrocalcinosis 
can be distinguished: 1) pelvic nephrocalcinosis; 2) corticomedullary nephrocalcinosis; 
and 3) calculus formation. Acute Tubular nephropathy is also frequently observed. All 
four conditions are relatively common in untreated laboratory rats, particularly in older 
animals, and strain and sex difference have also been observed. 
Many sugars, sugar alcohols and more complex carbohydrates, including dextrins and modified 
starches, enhance the absorption of calcium from the gut. It seems that low digestibility 
and delayed absorption of cabohydrate in the jejunum is associated with caecal enlargement 
and degradation of the carbohydrate in the ileum and caecum by bacterial enzymes. The 
absorption of degraded carbohydrate, particularly the monosaccharides, at those sites 
is associated with increased calcium absorption, and in turn leads to increased excretion 
of calcium in the urine. 
High dietary concentrations of slowly digestible carbohydrates such as lactose, the 
occurrence of excess dietary Ca and P, an incorrect Ca/P,ratio, too little Mg or too 
little vitamin B, all contribute to the induction of renal changes, particularly in 
rats and mice. In turn his Leads to PN in long-term feeding studies, particularly in 
rats. 
A long-term feeding study in mice of modified starches and other substances revealed 
only slight evidence of PN and none of carcinogenic activity. A two-year chronic 
toxicity and multigeneration study in rats and two chemically modified maize starches 
showed a similar incidence of PN in controls as in test animals. The 30-60 days studies 
in hamsters fed modified starches in an incidentally Mg-deficient diet showed 
*  Reports of the Scientific Committee for Food, Second Series (1976) tubular necrosis of variable degree of severity especially when propylene oxide-modified 
starches were fed. No renal lesions were seen/ if the Mg level was about 2-3.5 times 
the officially recommended level in the diet. 
Metabolism studies on weanling rats fed modified starches at high dietary levels for 
1 year showed little evidence of PN despite higher total Ca and Ρ outputs. Similar 
studies on rats aged 9 months to 18 months produced clear evidence of PN especially if 
the basic diet contained excessive Ca and Ρ levels. A further elaborate study on rats 
fed modified starch at a high dietary level failed to induce PN but there was evidence 
of corticomedullary calcification. The incidence and severity of the lesions was 
reduced by lowering the Ρ content, increasing the Ca/P ration or increasing the Mg 
level tenfold. Propylene oxyde modification led to increased urinary Mg, Ca and Ρ 
cpncentrations. 
b) Addi.ţiona]l_şţud2eş_on_mgdif2ed_şţarcheş_in_grou 
The Committee also reviewed additional short-term, long-term and reproduction studies on 
starches previously classified into group B or C (9, 10). They noted that none of these 
studies determined any dose-response relationships. Information was also received about 
the results of two lifespan studies in rats on epichlorhydrin, a modifying agent for 
starch, which showed this substance to have carcinogenic activity. The substance is als 
strongly mutagenic. No Lifespan studies are available on propylene chlorohydrin, that 
will arise from modifying starch with propylene oxide, except for positive mutagenicity 
tests. 
CONCLUSIONS 
1. The Committee considered the evidence on the appearance and mechanism of formation of 
pelvic nephrocalcinosis (PN). This incidence of this lesion increased apparently with 
the degree of substitution of the starch, and with the age of animals when first exposed. 
The rat appeared to be a particularly sensitive species for developing PN, the finding 
being much rarer in mice and not present in the hamster. Slow degradation of carbohydrates 
in the upper intestine led to the formation of absorbable breakdown products in the lower 
intestine. This was associated with enhanced Ca absorption. The Committee considered this 
finding to be peculiar for the rat as the most sensitive species and to have little 
relevance for the safety assessment of modified starches for man. 
2. For these reasons the Committee was of the opinion that modified starches in group B 
can now be regarded as acceptable. Because these modified starches also contribute 
to the energy balance of the diet, the Committee considered it unnecessary to establish 
individual ADIs provided technological usage remained at present-day levels. The 
Committee requested that this aspect should be kept under review by the Commission. 
3. Starches modified with epichlorhydrin should not be used in food because of the 
carcinogenicity of epichlorhydrin. 
4. As regards baby foods the Committee accepted that starches in group B could be used in 
infant foods and foods for young children provided the maximum limits of 5% was not 
exceeded. The Committee however reaffirmed its previous advice that propylene oxide-
modified starches should not be used in foods for infants and young children. 
5. The Committee considers that modified starches in group C, modified with propylene 
oxide X.E 1440 and E 1442), could be transferred to group B provided residues of chlorohydrii 
do not exceed 0.1 mg/kg as determined by an agreed method. 
REFERENCES 
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*r 
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x. ŞICQN2_RIPQRŢ_0F_ŢHE_ŞCIENŢIFIC_C0MMIŢŢEE_F0R_F00D_0N_FLAy^ 
(Opinion expressed 11 December 1981) 
The Committee was asked as a matter of urgency to give its opinion on the proposal that 
nature-identical flavouring substances and natural flavouring materials should be regulated 
by using the negative list principle (i.e. substances and materials not expressly prohibited 
are to be considered as acceptable). 
In view of the constraints of time imposed on the Committee the present report should be 
considered as a summary of conclusions that can be justified with detail should the need 
arise. 
The Committee recognises the complexities of classification, specification and toxicological 
evaluation of the large number of substances involved and the problems of enforcement entailed 
by the elaboration of a list of permitted flavourings. The Committee reiterates the statement 
in its 10th Report that before an additive is accepted for use in food it should have been 
subjected to an adequate toxicological evaluation, and sees no reason, on the information 
available to it about flavourings to depart from this principle. 
A system which proposes that a substance or material could be used in food without evaluation 
until proof of danger would not be compatible with the Committee's interpretation of what 
was needed to protect public health. 
The fact that a substance occurs in food or has been synthesised to be identical to a 
substance occuring naturally in food or natural source material is no proof of its 
inherent safety. 
It is clear that nature identical substances, more than natural flavourings, are likely to 
be used in food in quantities exceeding the levels in which they are found in nature. The 
committee accepts the concept that nature identical substances do not differ fundamentally 
from their natural counterpart. However, toxic substances are found in nature and some 
occur in food and this justifies the position of the Committee that a positive list for 
nature identical substances and for source materials for the production of natural flavouring 
preparations is desirable. 
In its 10th Report the Committee acknowledged that special considerations may apply when 
evaluating the safety-in-use of flavourings and that priorities need to be established 
regarding the substances to be evaluated. At the same time due consideration should be given 
to the extent of the minimum toxicological examination required. 
Given the large number of substances involved an evaluation will take time and the 
Committee can understand those who state that the list of acceptable substances cannot be 
drawn up immediately. Indeed the Committee could accept that the list would have to be 
drawn up in stages according to agreed criteria for priorities. Experience and information 
has been accumulated by the Council of Europe, WHO, national authorities and organisations 
such as IOFI and the US F.E.M.A. on the usage, physico-chemical characteristics and toxi-
cological properties of flavouring substances. Therefore it should be possible to evaluate 
many flavourings in use on the basis of these data and to assess their acceptability or 
non-acceptability. The task should be carried out in such a way as to avoid duplication of 
effort among the various scientific bodies concerned in advising governments and inter-
national organisations. 
The Committee recognizes that there are political, legal and economic implications which have 
to be considered by the responsible authorities. Nevertheless it draws to their attention 
the conclusion of the Council of Europe's expert group that "any effective legal control 
must be based on positive lists". The Committee also notes that the application of the 
provisions of the 6th amendment to the Council Directive on the approximation of laws, 
regulations and administrative provisions relating to the classification, packaging and 
labelling of dangerous substances^, will influence the situation. 
179/831/EEC of 18.9.1979, 0J L 259 of 15.10.1979, p. 10 
11 REPORT OF THE SCIENTIFIC COMMITTEE FOR FOOD ON STYRENE MONOMER 
(Opinion expressed 5 March 1982) 
TERMS OF REFERENCE 
To evaluate the hazards to human heaLth arising from the migration into food of styrene 
monomer present in certain plastic materials and articles intended to come into contact 
with foodstuffs. 
DISCUSSION 
The Committee considered the technological and toxicological information available to it 
in 1978/1979 and suggested at that time that before making a final decision it should see 
the results of ongoing studies. In the intervening period the Committee recommended that 
on the basis of the then available evidence it would be necessary to achieve the lowest 
level of residual styrene monomer (SM) in the materials and articles that was technologicall) 
feasible and then to reduce migration of SM into food. These views were made known to the 
responsible authorites. 
Since that time other information has become available, including additional data on the 
toxicological effects of SM on man, experimental animals, and certain biological systems. 
Estimates have also been provided of the likely intake of SM in the human diet, which may 
range from 1-4 jug/day. 
The Committee has reviewed again all presently available data and concluded that the new 
information confirms the Committee's previous opinion that the data do not lead to the 
conclusion that SM is carcinogenic to animal species or to man. The available toxicological 
data are still insufficient to establish a TDI*. However, the Committee is aware of further 
ongoing studies and will review the situation when these data become available to it. 
CONCLUSION AND RECOMMENDATIONS 
The Committee has no objection on toxicological grounds to accepting the continued use of 
plastic materials and articles made with SM and intended to come into contact with food-
stuffs. Nevertheless because the Committee was unable to establish a TDI for this 
monomer it recommends that the levels of SM residues in materials and articles intended 
to come into contact with foodstuffs should be reduced as much as possible. 
Tolerable Daily Intake: see Reports of the Scientific Committee for Food, 6th Series (1978) 
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